NIH #1R01CA293602-01
Targeting HMGA1 Tumor-Stromal Networks in Pancreatic Carcinogenesis
Active
- Amount
- $432K
- Period
- 2024-07-01 → 2029-06-30
- PIs
- 2
- Est. capacity / PI
- ~2 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P01CA247886-05
Integration of neo-antigen vaccines and immune checkpoint therapy
Active
- Amount
- $391K
- Period
- 2021-06-01 → 2027-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA197296-10
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
Active
- Amount
- $555K
- Period
- 2015-07-21 → 2027-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA293602-02
Targeting HMGA1 Tumor-Stromal Networks in Pancreatic Carcinogenesis
- Amount
- $438K
- Period
- 2024-07-01 → 2026-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA197296-09
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
- Amount
- $530K
- Period
- 2015-07-21 → 2026-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P01CA247886-04
Transforming Human Pancreatic Cancer Into An Immunologic Disease
- Amount
- $2.5M
- Period
- 2021-06-01 → 2026-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P01CA247886-03
Administrative Core
- Amount
- $100K
- Period
- 2021-06-01 → 2026-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA197296-08
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
- Amount
- $553K
- Period
- 2015-07-21 → 2026-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA197296-07
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
- Amount
- $557K
- Period
- 2015-07-21 → 2026-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P01CA247886-02
Transforming Human Pancreatic Cancer Into An Immunologic Disease
- Amount
- $2.5M
- Period
- 2021-06-01 → 2026-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #1P01CA247886-01A1
Transforming Human Pancreatic Cancer Into An Immunologic Disease
- Amount
- $2.6M
- Period
- 2021-06-01 → 2026-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #2R01CA197296-06
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
- Amount
- $581K
- Period
- 2015-07-21 → 2026-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA062924-28
Project 2: Neo-antigen Vaccines for Pancreatic and Colorectal Cancers
- Amount
- $339K
- Period
- 1997-02-28 → 2024-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA062924-27
Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies
- Amount
- $402K
- Period
- 1997-02-28 → 2023-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA062924-26
Project 2: Neo-antigen Vaccines for Pancreatic and Colorectal Cancers
- Amount
- $346K
- Period
- 1997-02-28 → 2023-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA197296-05
Reprogramming the pancreatic tumor microenvironment with immunotherapy
- Amount
- $590K
- Period
- 2015-07-21 → 2021-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA197296-04
Reprogramming the pancreatic tumor microenvironment with immunotherapy
- Amount
- $436K
- Period
- 2015-07-21 → 2020-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA197296-03
Reprogramming the pancreatic tumor microenvironment with immunotherapy
- Amount
- $430K
- Period
- 2015-07-21 → 2020-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA197296-02
Reprogramming the pancreatic tumor microenvironment with immunotherapy
- Amount
- $425K
- Period
- 2015-07-21 → 2020-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #1R01CA197296-01
Reprogramming the pancreatic tumor microenvironment with immunotherapy
- Amount
- $425K
- Period
- 2015-07-21 → 2020-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #4P50CA062924-23
Tumor Antigens for Individual Signatures and Therapy
- Amount
- $315K
- Period
- — → 2018-08-31
- PIs
- 1
- Est. capacity / PI
- ~5 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA184926-04
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
- Amount
- $766K
- Period
- 2014-05-01 → 2018-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA184926-03
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
- Amount
- $767K
- Period
- 2014-05-01 → 2018-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5R01CA184926-02
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
- Amount
- $768K
- Period
- 2014-05-01 → 2018-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #1R01CA184926-01
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
- Amount
- $799K
- Period
- 2014-05-01 → 2018-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA103175-10
Developmental Fund
- Amount
- $103K
- Period
- — → 2017-07-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA062924-22
Tumor Antigens for Individual Signatures and Therapy
- Amount
- $339K
- Period
- — → 2016-08-31
- PIs
- 1
- Est. capacity / PI
- ~5 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P30CA006973-52
CELL PROCESSING AND GENE THERAPY
- Amount
- $420K
- Period
- — → 2016-04-30
- PIs
- 1
- Est. capacity / PI
- ~6 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA062924-25
Project 2: Neo-antigen Vaccines for Pancreatic and Colorectal Cancers
- Amount
- $339K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~5 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #2P50CA062924-24A1
Project 4 :Using TME genetics and immunobiology to drive combination immunotherapies
- Amount
- $425K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~7 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #4P30CA006973-53
CELL PROCESSING AND GENE THERAPY
- Amount
- $420K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~6 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA062924-21
Tumor Antigens for Individual Signatures and Therapy
- Amount
- $336K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~5 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P50CA103175-09
Developmental Fund
- Amount
- $109K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P30CA006973-51
CELL PROCESSING AND GENE THERAPY
- Amount
- $403K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~6 students
Awarded at JOHNS HOPKINS UNIVERSITY
NIH #5P30CA006973-50
CELL PROCESSING AND GENE THERAPY
- Amount
- $392K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~6 students
Awarded at JOHNS HOPKINS UNIVERSITY